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Abstract 
Background: The aim of this study was to explore the impact of 6-Fr and 7-Fr 
sheaths on the incidence of long-term radial artery occlusion (RAO) after trans-radial 
coronary intervention (TRI). 
Methods: From September 2013 to January 2016, patients with ischemic heart 
disease including acute myocardial infarction and true bifurcation lesions were 
randomly assigned to 6-Fr group and 7-Fr group immediately after coronary 
angiography in a 1:1 ratio. The radial artery diameters were observed by ultrasound 
examination one day prior to TRI as well as at 30 days and one year after TRI. The 
primary endpoint was the incidence of RAO at 1-year after TRI. The secondary 
endpoints were the incidence of local vascular complications during hospitalization 
and changes of radial artery diameters within 1-year after TRI between the two groups. 
Additionally, multivariate logistic regression analysis was used to explore potential 
factors related to the incidence of long-term RAO after TRI. 
Results: A total of 214 patients were enrolled and randomly assigned to 6-Fr group (n 
= 105) or 7-Fr group (n = 109). There was no significant difference in the incidence of 
RAO at 1-year after TRI (8.57% vs. 12.84%, p = 0.313). Moreover, no significant 
difference was observed in the incidence of local vascular complications during 
hospitalization (20% vs. 24.77%, p = 0.403). After 1-year follow-up, no significant 
difference was found in radial artery diameters (2.63 ± 0.31 mm vs. 2.64 ± 0.27 mm, 
p = 0.802). Multivariate logistic analysis revealed that repeated TRI was an 
independent risk factor of long-term RAO one year after TRI (OR = 10.316, 95% CI 
2.928–36.351, p = 0.001). 
Conclusions: Compared to 6-Fr sheath, 7-Fr sheath did not increase short-term or 
long-term incidence of RAO after TRI. 
Key words: radial artery occlusion, trans-radial coronary intervention, radial 
artery diameter, artery sheath, local vascular complication 
 
Introduction 
With the rapid development of percutaneous coronary intervention (PCI) 
technique and persistent improvement of dedicated devices, trans-radial coronary 
intervention (TRI) has drastically advanced over the past two decades [1, 2]. 
Compared to conventional femoral artery access, TRI has significantly reduced the 
incidence of local vascular complications. More importantly, it has brought overall 
therapeutic benefits with lower mortality and fewer major adverse cardiac events 
(MACE) rates [3, 4]. Nowadays, the vast majority of patients undergoing TRI 
procedure, 6 French (6-Fr) sheaths and guiding catheters are recommended as the first 
choice [5]. Usually, it is possible to do most of percutaneous coronary intervention 
(PCI) procedures in regular cases through 6-Fr guiding catheters. However, 
sometimes it is difficult to conduct complex coronary procedures through 6-Fr 
guiding catheters, such as unprotected left main lesions, true bifurcation lesions 
treated with a two-stent strategy, severe calcified lesions requiring rotational 
atherectomy, and CTO lesions requiring multiple wires, balloons and specialized 
devices (e.g., microcatheter, child-mother catheter, 1.75-mm or larger burrs) 
simultaneously in one guiding catheter. Thus, a large-bore sheath (7-Fr) may be 
required to allow stronger back-up support and better materials delivery with no 
impact on hemodynamics monitoring and quality of coronary angiography, making 
the procedure easier and perhaps better [6]. Therefore, 7-Fr sheath and guiding 
catheters may be the better choice for complex coronary lesions as mentioned above. 
Radial artery occlusion (RAO) is the most common local vascular complication, 
with a reported incidence of between 0.8% and 30% [7, 8]. A previous study showed 
that a dis-match between radial artery inner diameter and sheath outer diameter was 
an independent risk factor for RAO after TRI [5]. In contrast, a previous study 
revealed that 7-Fr sheath did not increase the incidence of RAO at 30-day follow-up 
after TRI in comparison to 6-Fr sheath [9]. Furthermore, few studies have focused on 
the impact of 7-Fr sheath on long-term RAO after TRI with inconsistent conclusions 
[10–12]. Thus, the aim of this study was to explore the impact of 6-Fr and 7-Fr 
sheaths on the incidence of long-term RAO after TRI via vascular ultrasound. 
 
Methods 
Patient population and study design 
This study was a prospective, randomized, controlled trial. From September 
2013 to January 2016, patients with angina pectoris or evidence of myocardial 
ischemia and true bifurcation lesions confirmed by coronary angiography (CAG) in 
the Cardiology Department of the Second Hospital of Hebei Medical University were 
enrolled in this study. The true bifurcation lesions were defined as the diameter of side 
branch of more than 2 mm as well as degree of side branch ostium stenosis beyond 75% 
[9]. All coronary lesions were suitable for PCI treatment in this study. The exclusion 
criteria were: a negative Allen test, active inflammation, crossed over to other 
approaches (trans-femoral or trans-ulnar), repeated CAG or PCI via radial artery 
observed during the follow-up period, allergy to contrast agent, refusal to participate 
in the study, and inability to follow the protocol. The study protocol was approved by 
the ethics committee of the Second Hospital of Hebei Medical University (the IRB No. 
2013L-22). Informed consent was obtained from each participant before TRI 
procedure. The study was conducted in accordance with the Declaration of Helsinki. 
The enrolled patients were randomly assigned by computer-generated random 
numbers to either 6-Fr group or 7-Fr group immediately after CAG in a 1:1 ratio. 
Patients in 6-Fr group underwent PCI with 6-Fr sheaths (outer diameter: 2.52 mm, 
Radifocus, Terumo, Japan), while patients in 7-Fr group underwent PCI with 7-Fr 
sheaths (outer diameter: 2.85 mm, Medtronic, USA). Patients could cross-over to the 
other group if necessary. Before inserting the 7-Fr sheath, sufficient local 
subcutaneous anesthesia with lidocaine and intra-arterial nitroglycerin were 
administrated to avoid radial artery spasm. 
 
Trans-radial catheterization 
Coronary procedures were performed according to the standard technique of 
radial artery approach. The TRI was performed by the same experienced cardiac 
interventional team at a same center in both groups. The forearm was positioned 
beside the patient’s body and the wrist was hyperextended. After local subcutaneous 
anesthesia with 1% lidocaine, radial artery puncture was carried out using a 20-gauge 
needle (Terumo Co) using the Seldinger technique and a 0.025-in straight tip 
guidewire (Terumo Co) was inserted through the needle. After removing the needle, a 
16-cm 6-Fr hydrophilic sheath (Terumo Co) was placed over the guidewire. 
Subsequently, a bolus of unfractionated heparin (3000 IU) and 200 µg nitroglycerin 
was administered through the sheath. The CAG was performed with 4-Fr Judkins 
diagnostic catheters (Terumo Co) or 5-Fr TIG diagnostic catheters (Terumo Co). 
Moreover, weight-adjusted unfractionated heparin (70–100 IU/kg) was administered 
to maintain activated clotting time between 250–300 s during the PCI procedure. 
After TRI procedures, the radial arterial sheath was immediately pulled out and 
hemostasis (TR Band; Terumo Co) was achieved by radial compression. The TR Band 
was applied by inflating 13 to 15 mL of air at the puncture site. After each subsequent 
hour, the TR Band was gradually deflated (2–3 mL) until being completely removed. 
If there was bleeding during the deflation process, 2 mL of air would be injected to 
stop the bleeding and then was rechecked after 15 min.  
Procedural variables among the two groups such as radial artery diameter (RAD) 
to sheath size ratio (A/S ratio), number of punctures (a needle pushed even just inside 
the skin was counted as a single attempt, regardless of skin puncture times), number 
of catheters used, heparin dose, procedure time, compression time, forearm 
hematomas and volume of contrast media were observed and evaluated.  
 
Ultrasound examination 
An experienced vascular sonographer blinded to the patients performed 
ultrasound examinations using an ultrasound system (Terason T3000, the USA) with a 
5.0 to12.0 MHz linear transducer. Ultrasound-Doppler assessment of bilateral radial 
artery diameter, was conducted one-day before the procedure at point 3 to 5 cm 
proximal to the styloid process of the radius bone. In addition, the radial artery 
diameter was assessed in 30 days and one-year post TRI procedure. Moreover, the 
incidence of RAO in 1 year after TRI was observed, and was considered as the 
absence of antegrade flow in the radial artery observed by ultrasound.  
 
Study endpoints 
The primary endpoint of study was the incidence of RAO at 1 year after TRI 
between the two groups. On the other hand, the secondary endpoints of the study were 
the incidence of local vascular complications during hospitalization and radial artery 
diameter changes within 1 year after TRI in comparison to the baseline value before 
TRI between the two groups. The local vascular access-site complications included 
radial artery spasm (RAS), pseudoaneurysm, local hematoma, arteriovenous fistula 
and hand ischemia. The RAS was defined as a severe local pain and discomfort 
during catheter movement compelling the operator to stop the procedure and was 
confirmed by radial artery angiography. Local forearm hematomas were graded using 
the EASY classification [13].  
 
Statistical analysis 
Based on earlier studies it was speculated that at 1-year, the incidence of RAO 
after TRI procedure would be 6% in 6-Fr group and 19% in 7-Fr group [7]. 
Accordingly, at least 98 patients in each group were needed for a test power set at 0.8 
and statistical level (2-sided) at 0.05. Based on a 15% 1-year loss rate, at least 112 
patients were needed in each group. All calculations were analyzed with SPSS 
statistical software (version 17.0; SPSS Inc, Chicago, Illinois). The continuous 
variables were expressed as means ± standard deviation for normally distributed 
variables, while as median with interquartile range for non-normally distributed 
variables. The categorical variables were presented as percentages. Continuous 
variables were compared using the Student t test for normally distributed values and 
the Mann-Whitney U test for non-normally distributed values. For proportions, if the 
expected frequency was < 5, they were compared using the χ2 test or Fisher exact test. 
Multivariate logistic regression analysis was used to explore the possible factors 
associated with the incidence of long-term RAO after TRI. A 2-sided p < 0.05 was 
considered statistically significant. 
 
Results 
Baseline characteristics of the patients 
A total of 248 patients were enrolled and randomly divided into 6-Fr group (n = 
124) and 7-Fr group (n = 124). During PCI procedure, 4 patients in the 6-Fr group 
were crossed-over to the 7-Fr group owing to their clinical need. All 7-Fr sheaths 
were successfully inserted. During follow-up, 34 (13.7%) patients were excluded in 
this study, 15 patients in 6-Fr group (8 patients experienced repeated TRI, 5 patients 
were lost to follow-up and 2 patients died), and 19 patients in 7-Fr group (10 patients 
experienced repeated TRI, 7 patients were lost to follow-up and 2 patients died). 
Finally, a number of 214 patients were enrolled and divided into the 6-Fr group (n = 
105) and the 7-Fr group (n = 109) (Fig. 1). There were no significant differences in 
terms of age, gender, body mass index, risk factors of coronary artery disease, clinical 
presentation, previous TRI history or follow-up medication between the groups. The 
baseline clinical characteristics are shown in Table 1. 
 
Procedural characteristics of the patients 
No significant differences were found with respect to access artery, the number 
of puncture attempts, heparin dose, number of catheters used, volume of contrast 
medium or duration of compression. The ratio of radial artery inner diameter and 
sheath outer diameter in 6-Fr group was much higher than that in 7-Fr group (1.09 ± 
0.11 vs. 0.96 ± 0.13, p < 0.001). Besides, the procedural time of 6-Fr group was much 
longer than that of 7-Fr group (74.27 ± 12.58 min vs. 66.67 ± 14.72 min, p < 0.001). 
The procedural characteristics are shown in Table 2. 
 
Incidence of RAO at 1 year after TRI 
Overall, RAO occurred in 23 (10.75 %) of the 214 patients (9 patients in 6-Fr 
group and 14 patients in 7-Fr group). Besides, all patients were asymptomatic and 
there was no incidence of acute hand ischemia. There was no significant difference of 
incidence of RAO in 1 year after TRI between the two groups (8.57% vs. 12.84%, p = 
0.313) (Fig. 2).  
 
Peri-procedure local vascular complications 
There was no significant difference observed for the incidence of local vascular 
complications during hospitalization between the two groups (20% vs. 24.77%, p = 
0.403). Moreover, there was no difference in RAO during hospitalization between the 
6-Fr (5.71%) and 7-Fr groups (7.34%, p = 0.613).  Additionally, no obvious 
difference was found in the incidence of RAS, pseudoaneurysm, local hematoma, 
arteriovenous fistula and hand ischemia between the two groups (Table 3). 
 
Change of radial artery diameters within 1-year after TRI 
There was no significant difference of radial artery diameters at baseline between 
the two groups (2.74 ± 0.28 mm vs. 2.73 ± 0.39 mm, p = 0.830) and 30-day follow-up 
(2.69 ± 0.39 vs. 2.73 ± 0.29 mm, p = 0.396). At one-year follow-up, radial artery 
diameters in both the 6-Fr and 7-Fr groups were significantly reduced compared with 
baseline values before TRI (6-Fr group: 2.64 ± 0.27 mm vs. 2.74 ± 0.28 mm, p = 
0.009; 7-Fr group: 2.63 ± 0.31 mm vs. 2.73 ± 0.39 mm, p = 0.031). However, no 
significant difference in radial artery diameters was found between the two groups at 
one-year follow-up (2.63 ± 0.31mm vs. 2.64 ± 0.27 mm, p = 0.802). The change of 
radial artery diameters within one-year after TRI are listed in Table 4 and Figure 3. 
 
Results of multiple logistic regression analysis 
Multivariate logistic analysis revealed that repeated TRI was an independent risk 
factor of long-term RAO in 1-year post TRI (odds ratio [OR] = 10.316, 95% 
confidence interval [CI] 2.928–36.351, p = 0.001). However, radial artery diameter, 
the ratio of radial artery inner diameter/sheath and outer diameter, and the sheath size 
of the artery were not independent predictors of long-term RAO after TRI (Table 5). 
 
Discussion 
In this study, it was revealed that 7-Fr sheath did not increase the long-term 
incidence of RAO after TRI compared to the 6-Fr sheath. Additionally, no apparent 
difference was observed on the radial artery diameter between 6-Fr and 7-Fr sheaths 
in 1 year after TRI, but both of them were significantly reduced compared to the 
baseline value before TRI. In addition, repeated TRI was an independent risk factor of 
long-term RAO after TRI but not the radial artery diameter, A/S ratio or artery sheath 
size. 
The use of the radial instead of the femoral approach is beneficial not only due to 
the reduction in the incidence of access-site complications, but also its capacity to 
reduce mortality and the risk of cardiac complications, especially in high-risk patients 
[14–16]. Moreover, the radial approach is also associated with more comfort for the 
patient, shorter hospitalization stays, and lower costs of treatment. However, RAO is 
one of the major complications of procedures performed via the radial artery [17, 18]. 
Although with an asymptomatic course, as well as the incidence of hand ischemia 
caused by RAO is extremely rare, RAO eliminates the ability to use the radial artery 
as an access for PCI in the future, to use it as a bypass conduit for patients undergoing 
coronary artery bypass surgery, or to use it for dialysis fistula. Previous studies have 
disclosed that RAO may be associated with the following factors such as female 
gender, diabetes, history of TRI, low dose of unfractionated heparin, longer 
hemostasis times, smaller radial artery and A/S ratio < 1 [7]. However, these findings 
have not been consistent among studies [19–22].  
Traditionally, complex PCI has been performed at the femoral but not the radial 
approach due to the need for large size catheters. The use of 7-Fr sheath is limited 
mainly via radial artery owing to a risk of RAO after TRI. In a Japanese study using 
ultrasound evaluation, the A/S ratio < 1 predicted lower blood flow in radial artery 
after TRI procedure, but the impact on RAO has not been evaluated [5]. Besides, 
Uhlemann et al. [23] found that among 455 patients randomized to 5-Fr or 6-Fr 
sheaths, the 6-Fr sheaths were associated with a significant higher incidence in RAO 
(13.7% vs. 30.5%, p < 0.001). A previous study however, showed that 7-Fr sheath did 
not increase the incidence of RAO at 30 days follow-up after TRI compared with 6-Fr 
sheath (2% vs. 3.9%, p = 0.70). In addition, in a single center registry [11], 175 
patients were subjected to TRI via radial artery through a 7-Fr Radifocus® Introducer 
II (Terumo Corporation, Tokyo, Japan) with a 6-month follow-up, which observed an 
RAO  rate of 6% (95% CI 3–11%) at manual assessment and 7% (95% CI 4–12%) at 
Doppler evaluation, consistent to those reported in previous studies (ranging from 5% 
to 38%) using a 6-Fr sheath. 
Nevertheless, all studies mentioned above were not randomized with a 
short-term follow-up, hence a bias in their selection may have occurred. Therefore, 
this prospective, randomized, controlled trial was conducted, and showed that 7-Fr 
sheath did not increase the long-term incidence of RAO after TRI compared with the 
6-Fr sheath.  
The reasons why 7-Fr sheath did not increase the long-term incidence of RAO 
after TRI may be associated with the following factors. Firstly, as a relatively 
high-volume TRI center, the operators have a rich experience of using 7-Fr sheath via 
radial artery access. The high success rate of single puncture (97–99%) may, to some 
extent, reduce injury to the radial artery. Moreover, the diameter of the radial artery, as 
measured by vascular ultrasound, is not a constant but a variable parameter. The 
diameter of radial artery can be reduced by stimuli and increased by intra-arterial 
administration of vasodilatory drugs such as nitroglycerin and verapamil. In this study, 
before insertion of 7-Fr sheath, sufficient local subcutaneous anesthesia with lidocaine 
and intra-arterial nitroglycerin were administrated to decrease radial artery spasm and 
increase the compatibility between radial artery and sheath with a lower vascular 
resistance. Finally, patent hemostasis and adequate anticoagulation have also played 
important roles in preventing RAO. 
Another interesting finding was that the radial artery diameter at 1-year 
follow-up after TRI was significantly lower than baseline value before TRI in both of 
6-Fr and 7-Fr groups, however, no obvious difference was observed between the two 
groups. Previous studies documented that TRI was related to intimal hyperplasia in 
the cannulated radial artery, as revealed by vascular imaging modalities such as 
intravascular ultrasound and optical coherence tomography [24–26]. In addition, 
recent studies have shown that the TRI procedure may lead to impaired flow-mediated 
dilation during long-term follow-up, which has been widely used for the non-invasive 
assessment of endothelium-dependent vasodilation response [27–29]. Therefore, it 
was assumed that the reduction of radial artery diameter may be associated with 
structural damage and impaired endothelial function of the cannulated radial artery 
due to chronic inflammatory and the proliferative process. This could explain why 
repeated TRI was an independent risk factor of long-term RAO at one year after TRI 
in the present study. 
The current study has several potential limitations. First, it is a relatively 
small-scale study, conducted in a single center. In addition, optical coherence 
tomography could have provided more details about structural damage such as intimal 
tears and medial dissections together with chronic intimal modifications but was not 
used. 
 
Conclusions 
In conclusion, this study showed that 7-Fr sheath did not increase the long-term 
incidence of RAO after TRI compared with 6-Fr sheath. Therefore, 7-Fr sheath in the 
radial artery access could be feasible and safe for complex coronary lesions, 
especially at experienced centers. 
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 Table 1. Baseline clinical characteristics between the two groups. 
Variables 
6-Fr group (n = 
105) 
7-Fr group (n = 
109) 
P 
Age [years] 58.08 ± 10.07 59.39 ± 9.31 0.325 
Male 75 (71.43%) 82 (75.22%) 0.529 
BMI [kg/m2] 25.39 ± 3.13 25.59 ± 2.42 0.587 
Hypertension 54 (51.43%) 59 (54.13%) 0.692 
Diabetes 35 (33.33%) 33 (30.28%) 0.631 
Hyperlipidemia 41 (39.05%) 43 (39.44%) 0.952 
Current smoking 36 (34.28%) 40 (36.69%) 0.712 
Clinical presentation:    
   Stable angina  4 (3.81%) 3 (2.75%) 0.664 
   Unstable angina  72 (68.57%) 74 (67.89%) 0.968 
   NSTEMI 23 (21.90%) 27 (24.77%) 0.738 
   STEMI 6 (5.72%) 5 (4.59%) 0.948 
Previous TRI history 29 (27.62%) 33 (30.28%) 0.668 
Follow-up medication:    
ASA 105 (100%) 109 (100%) NS 
Clopidogrel 78 (74.28%) 80 (73.39%) 0.882 
Ticagrelor 27 (25.72%) 29 (26.61%) 0.882 
Statins 102 (97.14%) 107 (98.17%) 0.621 
ACEI/ARB 45 (42.86%) 47 (43.12%) 0.969 
Beta-blocker 72 (68.57%) 77 (70.64%) 0.742 
ASA — acetylsalicylic acid; ACEI — angiotensin-converting enzyme inhibitor; ARB 
— angiotensin receptor blocker; BMI — body mass index; LVEF — left ventricular 
ejection fraction; NS — not significant; STEMI — ST-segment elevation myocardial 
infarction; NSTEMI — non-ST-segment elevation myocardial infarction; TRI — 
transradial coronary intervention  
 
 
Table 2. Procedural characteristics between the two groups. 
Variables 6-Fr group (n = 105) 7-Fr group (n = 109) P  
Access artery:   0.353 
   Right radial artery 97 (92.38%) 104 (95.41%)  
   Left radial artery 8 (7.62%) 5 (4.59%)  
A/S ratio 1.09 ± 0.11 0.96 ± 0.13 < 0.001 
Numbers of puncture: 1.12 ± 0.47 1.11 ± 0.37 0.813 
   Single puncture  97 (92.38%) 99 (90.82%) 0.479 
Anticoagulation drug:   0.658 
   Heparin 98 (93.33%) 100 (91.74%)  
   Bivalirudin 7 (6.67%) 9 (8.26%)  
Heparin dose [IU] 10409.52 ± 1836.83 10389.91 ± 1475.66 0.931 
Procedure time [min] 74.27 ± 12.58 66.67 ± 14.72 < 0.001 
Number of catheters  2.10 ± 0.33 2.08 ± 0.30 0.616 
Compression time [h] 6.93 ± 1.48 6.81 ± 1.42 0.526 
Use of GPI 18 (17.14%) 22 (20.18%) 0.196 
Volume of CM [mL] 162.24 ± 24.31 159.32 ± 24.77 0.385 
A/S — radial artery inner diameter/sheath outer diameter; CM — contrast medium; 
GPI — platelet glycoprotein IIb/IIIa inhibitor 
 
 
Table 3. Peri-procedure local vascular complications between two groups. 
Variables 
6-Fr group (n = 
105) 
7-Fr group (n = 
109) 
P 
Total number of complications 21 (20.00%) 27 (24.77%) 0.403 
RAO 6 (5.71%) 8 (7.34%) 0.631 
Radial artery spasm 10 (9.52%) 12 (11.01%) 0.721 
Forearm hematoma 9 (8.56%) 13 (11.93%) 0.419 
     ≤ II type 8 (7.61%) 11 (10.09%) 0.525 
     > II type 1 (0.95%) 2 (1.83%) 0.583 
Pseudoaneurysm 1 (0.95%) 0 (0%) NS 
Arteriovenous fistula 0 (0%) 0 (0%) NS 
Hand ischemia 0 (0%) 0 (0%) NS 
RAO — radial artery occlusion 
 
 
Table 4. Change of radial artery diameters between two groups. 
Variables 
6-Fr group (n = 
105) 
7-Fr group (n = 
109) 
P 
Baseline [mm] 2.74 ± 0.28 2.73 ± 0.39 0.830  
30 days after TRI [mm] 2.73 ± 0.29 2.69 ± 0.39 0.396 
1 year after TRI [mm] 2.64 ± 0.27* 2.63 ± 0.31* 0.802 
*Compared with baseline, p < 0.05; TRI — transradial coronary intervention 
 
 
Table 5. Predictors of radial artery occlusion by multivariate logistic analysis. 
Variables 
Radial artery occlusion 
OR 95% CI P 
Diabetes  0.945 0.269–3.317 0.930 
History of TRI 10.316 2.928–36.351 0.001 
Compression time 0.790 0.526–1.188 0.258 
Baseline radial artery diameter 1.964 0.218–8.413 0.239 
Radial artery spasm 1.871 0.444–7.891 0.393 
A/S < 1 0.561 0.056–5.640 0.624 
Artery sheath size 0.933 0.263–3.309 0.914 
A/S — radial artery inner diameter/sheath outer diameter; TRI — transradial coronary 
intervention 
 
 
  
Figure 1. Flow chart of this study; TRI — transradial coronary intervention. 
 
 
 
 
 
Figure 2. Incidence of radial artery occlusion (RAO) at 1 year after transradial 
coronary intervention (TRI). 
 
 
 
 
Figure 3. Change of radial artery diameters within 1-year after transradial coronary 
intervention (TRI); *Compared with the baseline value, radial diameters were 
significantly decreased in both groups, p < 0.05. 
